terbutaline sulfate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
BRICANYL terbutaline sulfate 0.5 mg/1mL injection ampoule
AUST R: 12068
Active ingredients:
terbutaline sulfate

Dosage form:
Injection, solution

Sponsor:
AstraZeneca Pty Ltd

Phone:
1800805342

From
21 Dec 2025
to
31 Jan 2026

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
The sponsor is closely controlling the supply.